<DOC>
	<DOCNO>NCT02253927</DOCNO>
	<brief_summary>The primary objective explore relative bioavailability increase dos BILR 355 BS , sodium dodecyl sulfate-containing solid formulation ( SDS ) , combination ritonavir 100 mg explore dose-concentration proportionality increase dos . A secondary objective explore effect food pharmacokinetics BILR 355 ( SDS )</brief_summary>
	<brief_title>Dose Escalation Study Pharmacokinetics , Safety Tolerability After Single Dose Administration BILR 355 ( SDS ) Plus Low-dose Ritonavir Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Ritonavir</mesh_term>
	<criteria>1 . Males females meet inclusion/exclusion criterion , female pregnant nursing , agree use doublebarrier method birth control ( condom diaphragm plus spermicide ) throughout trial ( alone addition method birth control oral contraceptive ) 2 . Healthy HIV negative adult volunteer 3 . Age ≥18 ≤60 year 4 . BMI ≥18.5 BMI ≤29.9 kg/m2 5 . Ability give sign dated write informed consent prior admission study accordance Good Clinical Practice ( GCP ) local regulation 1 . Gastrointestinal , hepatic , renal , respiratory , cardiovascular , metabolic , immunological hormonal disorder 2 . Surgery gastrointestinal tract ( except appendectomy ) 3 . Diseases central nervous system ( epilepsy ) psychiatric disorder neurological disorder 4 . History relevant orthostatic hypotension , faint spell blackouts 5 . Chronic relevant acute infection 6 . History allergy/hypersensitivity ( include drug allergy ) deem relevant trial judge investigator 7 . Intake drug long halflife ( &gt; 24 hour ) within least one month prior study drug administration trial 8 . Use drug within 10 day prior administration trial might reasonably influence result trial 9 . Participation another trial investigational drug within two month prior administration trial 10 . Current smoker 11 . Alcohol abuse ( 60 g/day ) 12 . Drug abuse ( positive urine test illicit prescription nonprescription drug drug abuse ) 13 . Blood donation ( 100 mL within four week prior study drug administration trial ) 14 . Excessive physical activity ( within one week prior study drug administration trial ) 15 . Any laboratory value outside reference range clinical relevance screening , accord judgment investigator 16 . Inability comply dietary regimen require protocol 17 . Infected hepatitis B hepatitis C virus ( define either hepatitis B surface antigen , hepatitis C antibody positive ) 18 . Pregnant lactating female</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>September 2014</verification_date>
</DOC>